The US President's Cancer Panel: A Model For Gathering Country-Level Input to Inform Cancer Control Policy and Program Initiatives
JCO Global Oncology · 2023
DOI: 10.1200/go.22.00410 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JCO Global Oncology, 2023. Verfasst von Lisa J Paradis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Former Employee of US National Cancer Institute (2011-2018), Rockville, MD. Hauptthemen laut MEDLINE: Policy, Neoplasms. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE The President's Cancer Panel (Panel) is a federal advisory committee charged with monitoring the US National Cancer Program and reporting directly to the US President. Since its creation a half century ago, the Panel has gathered input from individuals and organizations across the US cancer community and beyond and recommended actions to accelerate progress against cancer. The Panel is unique in its structure and function, and merits examination for its potential applicability in other settings worldwide. METHODS We present an overview of the general President's Cancer Panel model and describe the noteworthy and unique characteristics of the Panel that help achieve its charge. We also detail the specific processes, outputs, and achievements of the Panel appointed by President Barack Obama, which served between 2012 and 2018. RESULTS From 2012 to 2018, the Panel focused on three topics that addressed timely issues in cancer prevention and control: (1) HPV vaccination for cancer prevention, (2) connected health and cancer, and (3) value and affordability of cancer drug treatment. The Panel held 11 meetings with 165 participants who provided diverse perspectives on these issues. Four reports were delivered to the president, which were cited about 270 times in the literature. Over 20 collaborator activities, including commitments of funding, can be linked to the recommendations published in these reports. CONCLUSION The US President's Cancer Panel highlights the importance of independent advisory bodies within a national cancer control program and of national leadership support for the cancer community. The structure and function of the Panel could be applicable in other settings worldwide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Former Employee of US National Cancer Institute (2011-2018), Rockville, MD.
- US National Cancer Institute, Rockville, MD.
ORCID-Profile: Lisa J Paradis, Mishka Kohli Cira, Rachel Hanisch
Zitieren
APA
Paradis, L. J., Chao, A., Rimer, B. K., Sandler, A. B., Duncan, K., Cira, M. K., & Hanisch, R. (2023). The US President's Cancer Panel: A Model For Gathering Country-Level Input to Inform Cancer Control Policy and Program Initiatives. JCO Global Oncology. https://doi.org/10.1200/go.22.00410
Vancouver
Paradis LJ, Chao A, Rimer BK, Sandler AB, Duncan K, Cira MK, et al. The US President's Cancer Panel: A Model For Gathering Country-Level Input to Inform Cancer Control Policy and Program Initiatives. JCO Global Oncology. 2023. doi:10.1200/go.22.00410
BibTeX
@article{Paradis2023,
author = {Paradis, Lisa J and Chao, Ann and Rimer, Barbara K and Sandler, Abby B and Duncan, Kalina and Cira, Mishka Kohli and Hanisch, Rachel},
title = {The US President's Cancer Panel: A Model For Gathering Country-Level Input to Inform Cancer Control Policy and Program Initiatives},
journal = {JCO Global Oncology},
year = {2023},
doi = {10.1200/go.22.00410}
}
EUVIMED